The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates

NCT00722722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Bortezomib

Sponsor

Mayo Clinic

Collaborators

[object Object]